CLDX icon

Celldex Therapeutics

131 hedge funds and large institutions have $1.17B invested in Celldex Therapeutics in 2021 Q2 according to their latest regulatory filings, with 40 funds opening new positions, 33 increasing their positions, 36 reducing their positions, and 24 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more capital invested

Capital invested by funds: $ → $

more funds holding in top 10

Funds holding in top 10:

more funds holding

Funds holding:

1.83% more ownership

Funds ownership: 87.2%89.03% (+1.8%)

8% less repeat investments, than reductions

Existing positions increased: 33 | Existing positions reduced: 36

15% less call options, than puts

Call options by funds: $33.4M | Put options by funds: $39.5M

Holders
131
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
5
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$33.4M
Puts
$39.5M
Net Calls
Net Calls Change

Top Sellers

1 -$20.2M
2 -$17.5M
3 -$12.6M
4
VC
Vivo Capital
California
-$10.8M
5
Millennium Management
Millennium Management
New York
-$10.4M
Name Holding Trade Value Shares
Change
Change in
Stake
26
$12M
27
$11.4M
28
$11.3M
29
$10.8M
30
$9.53M
31
$7.66M
32
$5.86M
33
$4.75M
34
$4.54M
35
$4.5M
36
$4.12M
37
$4.02M
38
$3.89M
39
$3.56M
40
$3.54M
41
$3.51M
42
$3.27M
43
$3.11M
44
$2.93M
45
$2.92M
46
$2.8M
47
$2.63M
48
$2.63M
49
$2.57M
50
$2.38M